Trial intelligence / Profile preview

Emodepside vs Mebendazole in Soil-transmitted Helminthiasis

NCT06736691Phase 3Completed

Sponsor
Swiss Tropical and Public Health Institute
Start
Nov 2025
Primary completion
Jul 2026
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of emodepside in trichuriasis (2 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoint: Cured of T. trichiura infection. Started Nov 2025; status: completed.

02

Drugs

emodepside
03

Conditions

trichuriasis

Beyond the preview

Go deeper on NCT06736691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06736691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call